In vivo CAR-T therapy: Delivery systems and beyond for addressing expression, persistence, and safety challenges

Ziyi Zhang, Xingxing Shang, Tong Zhang, Dianwen Ju

Open source

DOI
10.1016/j.apsb.2026.08.030
Published
2026-11
Container
Acta Pharmaceutica Sinica B
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.apsb.2026.08.030,
  title = {In vivo CAR-T therapy: Delivery systems and beyond for addressing expression, persistence, and safety challenges},
  author = {Ziyi Zhang and Xingxing Shang and Tong Zhang and Dianwen Ju},
  year = {2026},
  journal = {Acta Pharmaceutica Sinica B},
  doi = {10.1016/j.apsb.2026.08.030},
  url = {https://doi.org/10.1016/j.apsb.2026.08.030}
}

RIS

TY  - JOUR
TI  - In vivo CAR-T therapy: Delivery systems and beyond for addressing expression, persistence, and safety challenges
AU  - Ziyi Zhang
AU  - Xingxing Shang
AU  - Tong Zhang
AU  - Dianwen Ju
PY  - 2026
JO  - Acta Pharmaceutica Sinica B
DO  - 10.1016/j.apsb.2026.08.030
UR  - https://doi.org/10.1016/j.apsb.2026.08.030
ER  - 

APA

Zhang, Z., Shang, X., Zhang, T., & Ju, D. (2026). In vivo CAR-T therapy: Delivery systems and beyond for addressing expression, persistence, and safety challenges. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.08.030

Source records